Archives
-
Cyanine 5-dCTP for Fluorescent DNA Workflows
2026-09-21
Cyanine 5-dCTP enables direct red-fluorescent labeling during DNA synthesis, supporting PCR products, hybridization probes, and structured oligonucleotide workflows. This guide combines practical starting conditions with the reference study’s DNA-framework insight to improve signal, enzyme access, and assay reproducibility.
-
CX-5461 Drives Mitotic Catastrophe in Cervical Cancer
2026-09-20
A June 2026 study shows that CX-5461, an RNA polymerase I inhibitor, suppresses cervical cancer cell growth by coupling Pol I inhibition to ATM/ATR-associated DNA damage, dysregulated mitotic entry, and mitotic catastrophe. The work also identifies enhanced cisplatin sensitivity, providing a mechanistic rationale for investigating CX-5461 in platinum-resistant cervical cancer models.
-
SR-202: PPARγ Antagonist Workflow Guide
2026-09-19
SR-202 enables controlled interrogation of PPARγ-dependent adipogenesis, macrophage polarization, and metabolic inflammation. This workflow guide translates evidence from an octanoic acid enteral-nutrition study into practical antagonist, control, and troubleshooting strategies for insulin resistance research, obesity research, and related immunometabolic assays.
-
Sulfachloropyridazine: A Translational Research Guide
2026-09-18
Sulfachloropyridazine is a sulfonamide antibacterial agent whose value extends from DHPS biochemistry to susceptibility, infection, and microbiome research. This guide presents a translational framework for selecting assays and interpreting drug-associated ecological changes without confusing correlation with mechanism.
-
HPF for Mapping hROS in Nanodynamic Therapy
2026-09-18
HPF (hydroxyphenyl fluorescein) offers selective highly reactive oxygen species detection for mechanistic studies of nanodynamic therapy. This guide shows how to use its hROS readout to distinguish oxidative injury from photodynamic, chemodynamic, and cuproptosis-associated effects.
-
Pifithrin-α: Practical p53 Inhibition Workflows
2026-09-17
Pifithrin-α (PFTα) provides a controllable way to test how p53 shapes apoptosis, ferroptosis, DNA-damage responses, and neuronal injury. This guide converts a maternal deltamethrin neurotoxicity study into practical cell-based workflows, assay controls, and troubleshooting strategies.
-
Propidium Iodide in Placental Immune Assays
2026-09-17
Propidium iodide is more than a routine viability stain: it can clarify membrane integrity, apoptosis interpretation, and assay design in trophoblast–immune cell models. This article connects PI measurement with findings on placental exosomes, miR-519d-3p, and preeclampsia while defining practical limits.
-
CPSIT_0844 Activates TLR2/TLR4 Inflammation
2026-09-16
The reference study identifies the Chlamydia psittaci inclusion membrane protein CPSIT_0844 as a proinflammatory factor that induces IL-6 and IL-8 in human monocytes. Its experiments connect this response to TLR2/TLR4–MyD88 signaling and downstream JNK, p38, and NF-κB activation, providing a mechanistic framework for studying C. psittaci immunopathology.
-
PSA-CD56/Siglec-7 Immune Evasion in ccRCC
2026-09-16
A 2026 study identifies polysialylated CD56 as a glyco-immune checkpoint that engages Siglec-7 on CD8 T cells in clear cell renal cell carcinoma. The findings connect tumor glycosylation with impaired T-cell cytokine production, T-cell apoptosis, tumor progression, and reduced immunotherapy responsiveness, while providing a rationale for testing blockade of the PSA-CD56/Siglec-7 axis.
-
Thiazovivin A5506: ROCK Inhibitor Workflow Guide
2026-09-15
Thiazovivin (A5506) is a ROCK inhibitor used to support fibroblast reprogramming for induced pluripotent stem cell generation and human embryonic stem cell survival after trypsinization. This guide covers preparation, controls, storage, and troubleshooting, while defining the limits of dossier-based evidence and excluding diagnostic, clinical, and medical use.
-
Laminin (925-933): From Ligand to Assay Logic
2026-09-15
Laminin (925-933) is more than a defined cell adhesion peptide: it is a mechanistic probe for separating receptor-mediated signaling from complex matrix effects. This article connects its assay utility with lessons from site-specific tau research while defining practical limits for interpretation.
-
Clarithromycin: Designing Better CYP3A Studies
2026-09-14
Clarithromycin is a practical CYP3A inhibitor for investigating drug-drug interactions, statin metabolism, and pharmacokinetic behavior. This article presents a translational framework that connects assay controls with the CYP-independent disposition insights from dabigatran research.
-
Cyclic Pifithrin-α hydrobromide Workflows
2026-09-14
Build cleaner p53 perturbation experiments with a practical workflow for apoptosis, DNA-damage, growth-arrest, and irradiation studies. The article also explains how the compound can be used as an exploratory control when interpreting neuroinflammation findings, without overstating evidence outside validated p53 models.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-13
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection and signal amplification for rabbit primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, flow cytometry, and fluorescence microscopy. It should not be used as a substitute for a species-matched secondary antibody or in workflows incompatible with its sodium azide-containing buffer.
-
Thiamet G for Reliable O-GlcNAc Assays
2026-09-12
This scenario-based guide explains how Thiamet G (SKU B2048) can support controlled O-GlcNAc manipulation in viability, proliferation, cytotoxicity, tauopathy, and leukemia workflows. It covers dose selection, solution handling, orthogonal readouts, vendor evaluation, and interpretation of model-specific results.